Congress:
ECR25
Poster Number:
C-28368
Type:
Poster: EPOS Radiologist (educational)
Authorblock:
J. Hunter, J. Burns, M. Fitzsimons, D. Caldwell, M. J. O'Connell, P. Gilligan; Dublin/IE
Disclosures:
Jonathan Hunter:
Nothing to disclose
Jane Burns:
Nothing to disclose
Michael Fitzsimons:
Nothing to disclose
David Caldwell:
Nothing to disclose
Martin Joseph O'Connell:
Nothing to disclose
Paddy Gilligan:
Nothing to disclose
Keywords:
Hybrid Imaging, Molecular imaging, Oncology, PET-CT, Education, Molecular imaging, Education and training, Multidisciplinary cancer care
Since its introduction, PSMA PET/CT has become a vital tool in in the primary diagnosis and staging prostate cancer, as well as, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. It has led to a shift away from traditional algorithms, introduced the field of theranostics, and brought attention to as many uncertainties as it has advancements. The advent of PSMA PET/CT has highlighted the limitations of our conventional staging imaging and may even have a greater influence on patient treatment and allow clinicians to make more informed treatment decisions.